B&E Bio-tech attend Medlab Dubai Exhibition 5-8 February 2024.
B&E Bio-tech recently concluded its successful participation at the prestigious Medlab Dubai exhibition. Held at the Dubai World Trade Centre, B&E’s booth was a hub of activity as it presented its a great variety of diagnostic solutions including bio-sensor technology based electrolyte analyzer CBS5, hematology analyzer models Hemax33, Hemax53, Hemax530AL and the newly-launched hand-held blood gas analyzer i-check to a diverse audience hailing from across the Middle East and Africa.
During the event, which is recognized as one of the world’s largest gatherings for laboratory and diagnostics professionals, B&E showcased its commitment to excellent quality and continuous innovation. The highlight of the company’s exhibit was the hand-held blood gas analyzer i-chek, an intelligent POCT device that has great potential to lead the new trend of portable blood gas anslyzer.
The extensive product line-up also included CBS5 electrolyte analyzer, and the series of hematology analyzers - Hemax33, Hemax53, and the Hemax530AL, each designed to enhance laboratory efficiency and precision in blood analysis.
Throughout the Medlab Middle-east Exhibition, B&E welcomed a host of existing clients who provided positive feedback on the reliability and performance of their products. This enthusiastic endorsement from loyal customers served as a testament to B&E’s continuous dedication to quality and customer satisfaction.
Furthermore, the exhibition opened up new opportunities for B&E to forge partnerships and explore business prospects with numerous potential clients from the region. The interactive demonstrations and consultations conducted by B&E’s team were met with widespread acclaim, reinforcing the brand’s reputation for innovation and excellence within the international medical community.
As the curtains close on another successful Medlab Dubai, B&E emerges poised to expand its reach and influence in the Middle East and Africa, driven by its mission to provide reliable and accessible diagnostic technologies for better health outcomes worldwide.
